First randomized evaluation of safety, pharmacodynamics, and pharmacokinetics of BAY 1831865, an antibody targeting coagulation factor XI and factor XIa, in healthy men

por Nowotny, Bettina, Thomas, Dirk, Schwers, Stephan, Wiegmann, Sara, Prange, Wolfgang, Yassen, Ashraf, Boxnick, Stefanie
Publicado 2022